Biblio
Mesenchymal Stem/Stromal Cells Therapy For Metabolic Syndrome: Potential Clinical Application?. Stem Cells. 2023.
. Obesity and dyslipidemia are associated with partially reversible modifications to DNA hydroxymethylation of apoptosis- and senescence-related genes in swine adipose-derived mesenchymal stem/stromal cells. Stem Cell Res Ther. 2023;14(1):143.
Obesity blunts amelioration of cardiac hypertrophy and fibrosis by human mesenchymal stem/stromal cell-derived extracellular vesicles. Am J Physiol Heart Circ Physiol. 2023.
Obesity Blunts the Effect of Mesenchymal Stem Cell-Derived Extracellular Vesicles. Kidney Int Rep. 2023;8(9):1841-1851.
A Pseudotumor in a Mouse Kidney Following Human MSCs Injection. Stem Cell Rev Rep. 2023.
. Exogenous pericyte delivery protects the mouse kidney from chronic ischemic injury. Am J Physiol Renal Physiol. 2022.
. . .
Extracellular vesicles released by adipose tissue-derived mesenchymal stromal/stem cells from obese pigs fail to repair the injured kidney. Stem Cell Res. 2020;47:101877.
. . . Alterations in genetic and protein content of swine adipose tissue-derived mesenchymal stem cells in the metabolic syndrome. Stem Cell Res. 2019;37:101423.
. .
.
Intra-renal delivery of mesenchymal stem cells and endothelial progenitor cells attenuates hypertensive cardiomyopathy in experimental renovascular hypertension. Cell Transplant. 2014.
. Mesenchymal stem cell treatment for chronic renal failure. Stem Cell Res Ther. 2014;5(4):83.
. .